Jinxin Fertility Group Limited

Symbol: 1951.HK




Market price today

  • 22.1055

    P/E Ratio

  • 1.9093

    PEG Ratio

  • 6.74B

    MRK Cap

  • 0.00%

    DIV Yield

Jinxin Fertility Group Limited (1951-HK) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical - Care Facilities
CEO:Mr. Yang Dong
Full-time employees:3045
Address:No. 301, North Jingsha Road

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.421% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.172%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.124%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.023% return, is a testament to Jinxin Fertility Group Limited's adeptness in optimizing resource deployment. Jinxin Fertility Group Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.034%. Furthermore, the proficiency of Jinxin Fertility Group Limited in capital utilization is underscored by a remarkable 0.036% return on capital employed.

Liquidity Ratios

Analyzing 1951.HK liquidity ratios reveals its financial health of the firm. The current ratio of 79.44% gauges short-term asset coverage for liabilities. The quick ratio (67.35%) assesses immediate liquidity, while the cash ratio (36.94%) indicates cash reserves.

Current Ratio79.44%
Quick Ratio67.35%
Cash Ratio36.94%

Profitability Ratios

1951.HK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 16.65% underscores its earnings before tax deductions. The effective tax rate stands at 25.26%, revealing its tax efficiency. The net income per EBT, 74.25%, and the EBT per EBIT, 96.63%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 17.23%, we grasp its operational profitability.

Pretax Profit Margin16.65%
Effective Tax Rate25.26%
Net Income per EBT74.25%
EBT per EBIT96.63%
EBIT per Revenue17.23%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.79, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

Days of Sales Outstanding67
Days of Inventory Outstanding14
Operating Cycle51.45
Days of Payables Outstanding52
Cash Conversion Cycle-1
Receivables Turnover9.78
Payables Turnover6.98
Inventory Turnover25.85
Fixed Asset Turnover0.89
Asset Turnover0.19

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.25, and free cash flow per share, 0.19, depict cash generation on a per-share basis. The cash per share value, 0.31, showcases liquidity position. A payout ratio of 0.03 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.25, offers insight into cash flow relative to sales.

Operating Cash Flow per Share0.25
Free Cash Flow per Share0.19
Cash per Share0.31
Payout Ratio0.03
Operating Cash Flow Sales Ratio0.25
Free Cash Flow to Operating Cash Flow Ratio0.75
Cash Flow Coverage Ratio0.27
Short Term Coverage Ratio0.83
Capital Expenditure Coverage Ratio3.94
Dividend Paid and Capex Coverage Ratio3.72

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 17.11%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.25, we discern the balance between debt and equity financing. The long-term debt to capitalization, 14.63%, and total debt to capitalization, 20.17%, ratios shed light on its capital structure.

Debt Ratio17.11%
Debt Equity Ratio0.25
Long Term Debt to Capitalization14.63%
Total Debt to Capitalization20.17%
Cash Flow to Debt Ratio0.27
Company Equity Multiplier1.48

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.99, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.12, reflects the portion of profit attributed to each share. The book value per share, 3.59, represents the net asset value distributed per share, while the tangible book value per share, 0.17, excludes intangible assets.

Revenue Per Share0.99
Net Income Per Share0.12
Book Value Per Share3.59
Tangible Book Value Per Share0.17
Shareholders Equity Per Share3.59
Interest Debt Per Share0.93
Capex Per Share-0.06

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 17.95%, indicates top-line expansion, while the gross profit growth, 28.73%, reveals profitability trends. EBIT growth, 99.45%, and operating income growth, 99.45%, offer insights into operational profitability progression. The net income growth, 184.60%, showcases bottom-line expansion, and the EPS growth, 168.04%, measures the growth in earnings per share.

Revenue Growth17.95%
Gross Profit Growth28.73%
EBIT Growth99.45%
Operating Income Growth99.45%
Net Income Growth184.60%
EPS Growth168.04%
EPS Diluted Growth149.48%
Weighted Average Shares Growth12.72%
Weighted Average Shares Diluted Growth4.24%
Dividends per Share Growth-94.13%
Operating Cash Flow Growth26.35%
Free Cash Flow Growth222.33%
10-Year Revenue Growth per Share577.32%
5-Year Revenue Growth per Share154.48%
3-Year Revenue Growth per Share66.84%
10-Year Operating CF Growth per Share428.39%
5-Year Operating CF Growth per Share61.56%
3-Year Operating CF Growth per Share89.57%
10-Year Net Income Growth per Share231.12%
5-Year Net Income Growth per Share74.08%
3-Year Net Income Growth per Share16.88%
10-Year Shareholders Equity Growth per Share10619.34%
5-Year Shareholders Equity Growth per Share94.58%
3-Year Shareholders Equity Growth per Share18.21%
5-Year Dividend per Share Growth per Share-92.87%
3-Year Dividend per Share Growth per Share-94.01%
Receivables Growth7.57%
Inventory Growth-0.19%
Asset Growth-2.20%
Book Value per Share Growth3.62%
Debt Growth-38.78%
R&D Expense Growth24.45%
SGA Expenses Growth10.31%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 10,236,455,545.559, captures the company's total value, considering both debt and equity. Income quality, 1.47, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.17, gauges operational efficiency, while the research and development to revenue, 0.78%, highlights investment in innovation. The ratio of intangibles to total assets, 65.17%, indicates the value of non-physical assets, and capex to operating cash flow, -25.36%, measures reinvestment capability.

Enterprise Value10,236,455,545.559
Income Quality1.47
Sales General and Administrative to Revenue0.17
Research and Development to Revenue0.78%
Intangibles to Total Assets65.17%
Capex to Operating Cash Flow-25.36%
Capex to Revenue-6.22%
Capex to Depreciation-60.96%
Stock-Based Compensation to Revenue1.92%
Graham Number3.14
Return on Tangible Assets6.64%
Graham Net Net-1.28
Working Capital-347,385,000
Tangible Asset Value479,697,000
Net Current Asset Value-3,366,917,000
Average Receivables275,204,500
Average Payables234,058,500
Average Inventory62,486,500
Days Sales Outstanding37
Days Payables Outstanding52
Days of Inventory On Hand14

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.76, and the price to book ratio, 0.76, reflect the market's valuation relative to the company's book value. The price to sales ratio, 2.69, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 14.67, and price to operating cash flows, 11.13, gauge market valuation against cash flow metrics.

Price Book Value Ratio0.76
Price to Book Ratio0.76
Price to Sales Ratio2.69
Price Cash Flow Ratio11.13
Price Earnings to Growth Ratio1.91
Enterprise Value Multiple8.17
Price Fair Value0.76
Price to Operating Cash Flow Ratio11.13
Price to Free Cash Flows Ratio14.67
Price to Tangible Book Ratio0.82
Enterprise Value to Sales3.67
Enterprise Value Over EBITDA11.99
EV to Operating Cash Flow14.95
Earnings Yield4.15%
Free Cash Flow Yield6.15%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Jinxin Fertility Group Limited (1951.HK) on the HKSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 22.106 in 2024.

What is the ticker symbol of Jinxin Fertility Group Limited stock?

The ticker symbol of Jinxin Fertility Group Limited stock is 1951.HK.

What is company IPO date?

IPO date of Jinxin Fertility Group Limited is 2019-06-25.

What is company current share price?

Current share price is 2.450 HKD.

What is stock market cap today?

The market cap of stock today is 6739001630.000.

What is PEG ratio in 2024?

The current 1.909 is 1.909 in 2024.

What is the number of employees in 2024?

In 2024 the company has 3045.